ENANTA PHARMACEUTICALS INC (ENTA) › Net IncomeENANTA PHARMACEUTICALS INC (ENTA) — Net IncomeAnnual figures by fiscal year, from SEC filings.2011: $23.31M2012: $21.40M2013: $9.63M2014: $34.44M2015: $78.99M2016: $21.67M2017: $17.71M2018: $71.96M2019: $46.38M2020: -$36.17M2021: -$79.00M2022: -$121.75M2023: -$133.82M2024: -$116.05M2025: -$81.89M-$81.89M2011Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$81.89M+29.4%2024-$116.05M+13.3%2023-$133.82M-9.9%2022-$121.75M-54.1%2021-$79.00M-118.4%2020-$36.17M-178.0%2019$46.38M-35.5%2018$71.96M+306.3%2017$17.71M-18.3%2016$21.67M-72.6%2015$78.99M+129.4%2014$34.44M+257.7%2013$9.63M-55.0%2012$21.40M-8.2%2011$23.31M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share